These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7248992)

  • 1. Sequential combination chemotherapy for disseminated melanoma: a Southwest Oncology Group Study.
    Costanzi J; Fabian C; Wilson H; Dixon D
    Cancer Treat Rep; 1981; 65(7-8):732-4. PubMed ID: 7248992
    [No Abstract]   [Full Text] [Related]  

  • 2. Didemnin B in metastatic malignant melanoma: a phase II trial of the Southwest Oncology Group.
    Sondak VK; Kopecky KJ; Liu PY; Fletcher WS; Harvey WH; Laufman LR
    Anticancer Drugs; 1994 Apr; 5(2):147-50. PubMed ID: 8049497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present status of the melanoma problem].
    Braun W; Lübbe D; Wohlrab W; Wozniak KD; Zaumseil RP
    Dermatol Monatsschr; 1979 Oct; 165(10):732-40. PubMed ID: 393546
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy of melanoma].
    Bernheim JL; Kenis Y
    Acta Chir Belg; 1974 Mar; 73(2):249-63. PubMed ID: 4450922
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy in the treatment of malignant melanomas.
    Westbury G
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):445-7. PubMed ID: 274009
    [No Abstract]   [Full Text] [Related]  

  • 6. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procarbazine, vincristine, CCNU, and cyclophosphamide (POCC) in the treatment of metastatic malignant melanoma.
    Green MR; Dillman RO; Horton C
    Cancer Treat Rep; 1980 Jan; 64(1):139-42. PubMed ID: 7379047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of Cooperative Group evaluation criteria for multiple-drug therapy for breast cancer.
    Davis HL; Multhauf P; Klotz J
    Cancer Treat Rep; 1980; 64(2-3):507-17. PubMed ID: 7407792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical correlations of in vitro drug sensitivity.
    Salmon SE; Alberts DS; Meyskens FL; Durie BG; Jones SE; Soehnlen B; Young L; Chen HS; Moon TE
    Prog Clin Biol Res; 1980; 48():223-45. PubMed ID: 7193872
    [No Abstract]   [Full Text] [Related]  

  • 10. Yoshi 864 plus medroxyprogesterone acetate in adenocarcinoma of the kidney: A Southwest Oncology Group Study.
    Altman SJ; Stephens RL; Bonnet JD
    Cancer Treat Rep; 1982 Sep; 66(9):1781-2. PubMed ID: 6288240
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of generalized skin melanoma].
    Dement'eva NP; Koroleva LA
    Sov Med; 1981; (10):103-6. PubMed ID: 7313762
    [No Abstract]   [Full Text] [Related]  

  • 12. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
    Moschos SJ; Kirkwood JM; Konstantinopoulos PA
    J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
    [No Abstract]   [Full Text] [Related]  

  • 13. Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.
    Meier F; Guenova E; Clasen S; Eigentler T; Forschner A; Leiter U; Zielinski C; Knaudt B; Garbe C; Berneburg M
    J Am Acad Dermatol; 2009 May; 60(5):863-8. PubMed ID: 19389529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of cell kinetics in prediction of the response to cancer therapy.
    Tannock I; Frei E
    Natl Cancer Inst Monogr; 1971 Dec; 34():19-24. PubMed ID: 5140864
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of regional lymph node excision for prognosis of advanced malignant melanoma treated by perfusion of the extremity].
    Huber R; Krüger I; Stützer H
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():118-21. PubMed ID: 9101808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy (dacarbazine, carmustine, cisplastin, and tamoxifen) in advanced melanoma.
    Tan EH; Ang PT
    Singapore Med J; 1996 Apr; 37(2):165-7. PubMed ID: 8942255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of tamoxifen in patients with disseminated malignant melanoma.
    Creagan ET; Ingle JN; Green SJ; Ahmann DL; Jiang NS
    Cancer Treat Rep; 1980; 64(2-3):199-201. PubMed ID: 7407752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy and radiotherapy in the treatment of malignant tumors: indications and hazards].
    Bartelink H; Somers R
    Ned Tijdschr Geneeskd; 1980 Apr; 124(15):564-8. PubMed ID: 7374818
    [No Abstract]   [Full Text] [Related]  

  • 19. Individualized therapy of disseminated cancer using malignant melanoma as a model.
    Hauschild A; Egberts F; Russo P; Kähler KC
    Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Southwest Oncology Group experience with tamoxifen in metastatic melanoma.
    Reimer RR; Costanzi J; Fabian C
    Cancer Treat Rep; 1982 Aug; 66(8):1680-1. PubMed ID: 7049386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.